miRNA-106a Promotes Breast Cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity
- PMID: 30570350
- DOI: 10.1089/dna.2018.4282
miRNA-106a Promotes Breast Cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity
Abstract
To explore the effect of miR-106a in breast cancer cell behavior and sensitivity to chemotherapeutic agents. Tumor tissue and adjacent normal tissue were derived from 40 breast cancer patients, and miR-106a expression was measured by reverse transcription-qPCR. Breast cancer cells, MDA-MB-231 and MCF-7, were treated with miRNA-106a mimic (MM) or miRNA-106a inhibitor (MI) and negative controls. Cell proliferation was measured by MTT assay. Clonogenicity was measured by colony-forming assay. Cell migration and invasion ability were measured by scratch test and transwell assay, respectively. Apoptosis was determined by flow cytometry, and chemosensitivity to cisplatin was measured by MTT assay. Finally, protein expression of p53, Bax, Bcl-2, RUNX3, and ABCG2 was quantified by western blot. miR-106a expression was significantly upregulated in human breast cancer tissue relative to adjacent normal tissue. Upregulation of miR-106a enhanced breast cancer cell proliferation, colony-forming capacity, migration, and invasion of cultured breast cancer cells. Additionally, miR-106a overexpression significantly decreased breast cancer cell apoptosis and sensitivity to cisplatin. Finally, we showed miR-106a overexpression upregulated the levels of Bcl-2 and ABCG2, and downregulated the expression of P53, Bax, and RUNX3. miR-106a promotes breast cancer cell proliferation and invasion through upregulation of Bcl-2, ABCG2, and P53, and downregulation of Bax and RUNX3.
Keywords: breast cancer; cell behavior; chemosensitivity; miR-106a.
Similar articles
-
MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.Oncol Rep. 2017 Sep;38(3):1774-1782. doi: 10.3892/or.2017.5832. Epub 2017 Jul 18. Oncol Rep. 2017. PMID: 28731196
-
MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.Gene. 2017 Feb 5;600:21-28. doi: 10.1016/j.gene.2016.11.037. Epub 2016 Nov 29. Gene. 2017. PMID: 27913185
-
In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.Oncotarget. 2017 Feb 28;8(9):15507-15519. doi: 10.18632/oncotarget.14662. Oncotarget. 2017. PMID: 28099945 Free PMC article.
-
Expanding the Biotherapeutics Realm via miR-34a: "Potent Clever Little" Agent in Breast Cancer Therapy.Curr Pharm Biotechnol. 2019;20(8):665-673. doi: 10.2174/1389201020666190617162042. Curr Pharm Biotechnol. 2019. PMID: 31244419 Review.
-
Mechanism and function of miR-140 in human cancers: A review and in silico study.Pathol Res Pract. 2023 Jan;241:154265. doi: 10.1016/j.prp.2022.154265. Epub 2022 Dec 7. Pathol Res Pract. 2023. PMID: 36509008 Review.
Cited by
-
Doxorubicin and Cisplatin Modulate miR-21, miR-106, miR-126, miR-155 and miR-199 Levels in MCF7, MDA-MB-231 and SK-BR-3 Cells That Makes Them Potential Elements of the DNA-Damaging Drug Treatment Response Monitoring in Breast Cancer Cells-A Preliminary Study.Genes (Basel). 2023 Mar 12;14(3):702. doi: 10.3390/genes14030702. Genes (Basel). 2023. PMID: 36980974 Free PMC article.
-
LncRNA ST8SIA6-AS1 Promotes Cholangiocarcinoma Progression by Suppressing the miR-145-5p/MAL2 Axis.Onco Targets Ther. 2021 May 17;14:3209-3223. doi: 10.2147/OTT.S299634. eCollection 2021. Onco Targets Ther. 2021. PMID: 34040387 Free PMC article.
-
hsa-miR-33-5p as a Therapeutic Target Promotes Apoptosis of Breast Cancer Cells via Selenoprotein T.Front Med (Lausanne). 2021 Apr 27;8:651473. doi: 10.3389/fmed.2021.651473. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33987194 Free PMC article.
-
miR-17-5p promotes migration and invasion in breast cancer cells by repressing netrin 4.Int J Clin Exp Pathol. 2019 May 1;12(5):1649-1657. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933983 Free PMC article.
-
miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine.Noncoding RNA. 2024 Feb 21;10(2):16. doi: 10.3390/ncrna10020016. Noncoding RNA. 2024. PMID: 38525735 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous